These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25000502)

  • 1. Abbott RealTime HBV assay is more sensitive in detection of low viral load and little impacted by drug resistant mutation in chronic hepatitis B patients under nucleot(s)ide analogues therapy.
    Yeh ML; Huang CF; Huang CI; Liu SF; Yang HL; Hsieh MY; Huang JF; Dai CY; Chuang WL; Yu ML
    PLoS One; 2014; 9(7):e101790. PubMed ID: 25000502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of real time allele specific locked nucleic acid quantitative PCR for detection of HBV YIDD (ATT) mutation and evaluation of its application.
    Zeng Y; Li D; Wang W; Su M; Lin J; Chen H; Jiang L; Chen J; Yang B; Ou Q
    PLoS One; 2014; 9(2):e90029. PubMed ID: 24587198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHB.
    Cai SH; Lv FF; Zhang YH; Jiang YG; Peng J
    BMC Infect Dis; 2014 Feb; 14():85. PubMed ID: 24528480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B.
    Huang YJ; Chang CS; Peng YC; Yeh HZ; Yang SS
    PLoS One; 2017; 12(3):e0174046. PubMed ID: 28350873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and effect of secondary individualized therapy in chronic hepatitis B patients infected with the rtA181 mutation hepatitis B virus].
    Ji FZ; Wang L; Yang BH; Zhao JJ; Liu F; Xue Y; Li T
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):280-4. PubMed ID: 22964149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of detection and quantification of HBV DNA in chronic HBeAg negative and positive patients by Abbott RealTime HBV and Roche Cobas TaqMan HBV assays.
    Morris CJ; Hill M; de Medina M; Herman C; Cloherty GA; Martin P
    J Virol Methods; 2013 Nov; 193(2):391-3. PubMed ID: 23835030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.
    Hongthanakorn C; Chotiyaputta W; Oberhelman K; Fontana RJ; Marrero JA; Licari T; Lok AS
    Hepatology; 2011 Jun; 53(6):1854-63. PubMed ID: 21618260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A real-time PCR assay for the quantification of hepatitis B virus DNA and concurrent detection of YMDD motif mutations].
    Ağca H; Sayıner AA; Sengönül A; Simşek I; Akarsu M
    Mikrobiyol Bul; 2011 Oct; 45(4):664-76. PubMed ID: 22090297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of lamivudine-resistant hepatitis B virus mutants by type-specific TaqMan minor groove binder probe assay in patients with chronic hepatitis B.
    Yoshida S; Hige S; Yoshida M; Yamashita N; Fujisawa S; Sato K; Kitamura T; Nishimura M; Chuma M; Asaka M; Chiba H
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):59-64. PubMed ID: 18275675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a new sensitive PCR assay for quantification of viral DNA isolated from patients with hepatitis B virus infections.
    Thibault V; Pichoud C; Mullen C; Rhoads J; Smith JB; Bitbol A; Thamm S; Zoulim F
    J Clin Microbiol; 2007 Dec; 45(12):3948-53. PubMed ID: 17942654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adefovir and lamivudine combination therapy in patients with entecavir-resistant chronic hepatitis B: antiviral responses and evolution of mutations.
    Yim HJ; Lee HJ; Suh SJ; Seo YS; Kim CW; Lee CD; Park SH; Lee MS; Park CK; Chae HB; Kim MY; Baik SK; Kim YS; Kim JH; Lee JI; Lee JW; Hong SP; Um SH
    Intervirology; 2014; 57(5):239-47. PubMed ID: 24993731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of genotypic resistance profile in chronic hepatitis B patients receiving nucleos(t)ide analogues in Huzhou, China.
    Qian F; Qin J; Li D; Ma Z; Zhang H; Jin F; Wang W
    J Infect Dev Ctries; 2016 Sep; 10(9):996-1002. PubMed ID: 27694733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Abbott RealTime HBV assay with the Roche Cobas AmpliPrep/Cobas TaqMan HBV assay for HBV DNA detection and quantification.
    Yeh ML; Huang CF; Hsieh MY; Huang JF; Dai CY; Yu ML; Chuang WL
    J Clin Virol; 2014 Jul; 60(3):206-14. PubMed ID: 24809730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA.
    Kim DH; Choi JW; Seo JH; Cho YS; Won SY; Park BK; Jeon HH; Shin SY; Lee CK
    Yonsei Med J; 2017 May; 58(3):552-556. PubMed ID: 28332360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of tenofovir-based rescue therapy for patients with drug-resistant chronic hepatitis B].
    Choi K; Lee HM; Jun BG; Lee SH; Kim HS; Kim SG; Kim YS; Kim BS; Jeong SW; Jang JY; Kim YD; Cheon GJ
    Korean J Gastroenterol; 2015 Jan; 65(1):35-42. PubMed ID: 25603852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Abbott and Da-an real-time PCR for quantitating serum HBV DNA.
    Qiu N; Li R; Yu JG; Yang W; Zhang W; An Y; Li T; Liu XE; Zhuang H
    World J Gastroenterol; 2014 Sep; 20(33):11762-9. PubMed ID: 25206280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of baseline antiviral resistance in treatment-naive chronic hepatitis B cases].
    Ergünay K; Kahramanoğlu Aksoy E; Simşek H; Alp A; Sener B; Tatar G; Us D; Hasçelik G
    Mikrobiyol Bul; 2013 Oct; 47(4):628-35. PubMed ID: 24237431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of LigAmp assay for sensitive detection of drug-resistant hepatitis B virus minor variants in comparison with standard nucleotide sequencing.
    Ismail AM; Sachithanandham J; Eapen CE; Kannangai R; Abraham P
    Mol Diagn Ther; 2014 Dec; 18(6):655-63. PubMed ID: 25208639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.
    Lee YS; Chung YH; Kim JA; Kim SE; Shin JW; Kim KM; Lim YS; Park NH; Lee HC; Lee YS; Suh DJ
    Liver Int; 2009 Apr; 29(4):552-6. PubMed ID: 19323782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of periodic detection of hepatitis B virus YVDD mutation by ultrasensitive real-time amplification refractory mutation system quantitative PCR during lamivudine treatment in patients with chronic hepatitis B.
    Zeng Y; Yang B; Wu Y; Chen J; Shang H; Chen X; Su M; Wu S; Lin J; Ou Q
    J Med Microbiol; 2015 Mar; 64(Pt 3):237-242. PubMed ID: 25596114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.